Skip to menu Skip to content Skip to footer
Professor Susan Jordan
Professor

Susan Jordan

Email: 
Phone: 
+61 7 336 55473

Overview

Background

Dr Jordan is a medically trained cancer epidemiologist who is currently Professor of Epidemiology at the School of Public Health. Before starting her PhD, she worked in rural and urban general practice for over 10 years and brings that clinical experience to her research. She is currently a NHMRC Leadership Fellow and leads projects on ovarian and thyroid cancers, examining aetiology, patterns of care and survival. Her research employs a broad range of methods including individual patient and clinician surveys, molecular epidemiology and pooling of consortia data, but she has particular expertise in large-scale data linkage.

Availability

Professor Susan Jordan is:
Available for supervision

Qualifications

  • Bachelor (Honours) of Medicine and Surgery and Medical Science, University of New South Wales
  • Graduate Diploma in Clinical Epidemiology, University of Newcastle
  • Doctor of Philosophy, The University of Queensland

Research interests

  • Cancer epidemiology

    I research the aetiology of ovarian, endometrial and thyroid cancers. I am particularly interested how reproductive factors are involved in the development of these cancers. I am also interested in factors associated with patterns of care for these cancers and in modifiable factors affecting survival

Research impacts

Dr Jordan's impacts contributions include: 1) the first comprehensive aetiological study to support the paradigm-shifting contention that most ovarian cancers arise in fallopian tubes rather than ovaries; 2) research on variations in ovarian cancer chemotherapy prompted revision of current ovarian cancer chemotherapy guidelines; 3) work in ovarian cancer survival, which received significant media attention, highlighted rural-urban disparities in cancer outcomes providing impetus to reduce this disparity; and demonstrating the risk reducing benefits of breast feeding for ovarian and endometrial cancer..

Works

Search Professor Susan Jordan’s works on UQ eSpace

186 works between 2003 and 2026

41 - 60 of 186 works

2022

Journal Article

Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia

Hurwitz, Lauren M., Townsend, Mary K., Jordan, Susan J., Patel, Alpa V., Teras, Lauren R., Lacey, James V., Doherty, Jennifer A., Harris, Holly R., Goodman, Marc T., Shvetsov, Yurii B., Modugno, Francesmary, Moysich, Kirsten B., Robien, Kim, Prizment, Anna, Schildkraut, Joellen M., Berchuck, Andrew, Fortner, Renée T., Chan, Andrew T., Wentzensen, Nicolas, Hartge, Patricia, Sandler, Dale P., O'Brien, Katie M., Anton-Culver, Hoda, Ziogas, Argyrios, Menon, Usha, Ramus, Susan J., Pearce, Celeste Leigh, Wu, Anna H., White, Emily ... Trabert, Britton (2022). Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia. Journal of Clinical Oncology, 40 (36) JCO2101900, 4207-4217. doi: 10.1200/jco.21.01900

Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia

2022

Journal Article

Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older (vol 114, djac050, 2022)

Tuesley, Karen M., Webb, Penelope M., Protani, Melinda M., Spilsbury, Katrina, Pearson, Sallie-Anne, Coory, Michael D., Donovan, Peter, Steer, Christopher, Stewart, Louise M., Pandeya, Nirmala and Jordan, Susan J. (2022). Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older (vol 114, djac050, 2022). Journal of the National Cancer Institute, 114 (8), 1206-1206. doi: 10.1093/jnci/djac118

Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older (vol 114, djac050, 2022)

2022

Journal Article

Germline BRCA variants, lifestyle and ovarian cancer survival

Gersekowski, Kate, Delahunty, Rachel, Alsop, Kathryn, Goode, Ellen L., Cunningham, Julie M., Winham, Stacey J., Pharoah, Paul, Song, Honglin, Jordan, Susan, Fereday, Sian, DeFazio, Anna, Friedlander, Michael, Obermair, Andreas and Webb, Penelope M. (2022). Germline BRCA variants, lifestyle and ovarian cancer survival. Gynecologic Oncology, 165 (3), 437-445. doi: 10.1016/j.ygyno.2022.03.020

Germline BRCA variants, lifestyle and ovarian cancer survival

2022

Journal Article

Nitrogen-based bisphosphonate use and ovarian cancer risk in women aged 50 years and older

Tuesley, Karen M., Webb, Penelope M., Protani, Melinda M., Spilsbury, Katrina, Pearson, Sallie-Anne, Coory, Michael D., Donovan, Peter, Steer, Christopher, Stewart, Louise M., Pandeya, Nirmala and Jordan, Susan J. (2022). Nitrogen-based bisphosphonate use and ovarian cancer risk in women aged 50 years and older. Journal of the National Cancer Institute, 114 (6), 878-884. doi: 10.1093/jnci/djac050

Nitrogen-based bisphosphonate use and ovarian cancer risk in women aged 50 years and older

2022

Journal Article

Response to Lehrer and Rheinstein

Tuesley, Karen M., Webb, Penelope M., Protani, Melinda M., Spilsbury, Katrina, Pearson, Sallie-Anne, Coory, Michael D., Donovan, Peter, Steer, Christopher, Stewart, Louise M., Pandeya, Nirmala and Jordan, Susan J. (2022). Response to Lehrer and Rheinstein. JNCI: Journal of the National Cancer Institute, 114 (10) djac083, 1427-1428. doi: 10.1093/jnci/djac083

Response to Lehrer and Rheinstein

2022

Journal Article

Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association

Khoja, Lilah, Weber, Rachel Palmieri, Webb, Penelope M., Jordan, Susan J., Muthukumar, Aruna, Chang-Claude, Jenny, Fortner, Renée T., Jensen, Allan, Kjaer, Susanne K., Risch, Harvey, Doherty, Jennifer Anne, Harris, Holly R., Goodman, Marc T., Modugno, Francesmary, Moysich, Kirsten, Berchuck, Andrew, Schildkraut, Joellen M., Cramer, Daniel, Terry, Kathryn L., Anton-Culver, Hoda, Ziogas, Argyrios, Phung, Minh Tung, Hanley, Gillian E., Wu, Anna H., Mukherjee, Bhramar, McLean, Karen, Cho, Kathleen, Pike, Malcolm C., Pearce, Celeste Leigh and Lee, Alice W. (2022). Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. Gynecologic Oncology, 164 (1), 195-201. doi: 10.1016/j.ygyno.2021.10.088

Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association

2022

Journal Article

Predicting obesity and smoking using medication data: a machine‐learning approach

Ali, Sitwat, Na, Renhua, Waterhouse, Mary, Jordan, Susan J., Olsen, Catherine M., Whiteman, David C. and Neale, Rachel E. (2022). Predicting obesity and smoking using medication data: a machine‐learning approach. Pharmacoepidemiology and Drug Safety, 31 (1), 91-99. doi: 10.1002/pds.5367

Predicting obesity and smoking using medication data: a machine‐learning approach

2022

Journal Article

Effects of risk factors for ovarian cancer in women with and without endometriosis

Phung, Minh Tung, Muthukumar, Aruna, Trabert, Britton, Webb, Penelope M., Jordan, Susan J., Terry, Kathryn L., Cramer, Daniel W., Titus, Linda J., Risch, Harvey A., Doherty, Jennifer Anne, Harris, Holly R., Goodman, Marc T., Modugno, Francesmary, Moysich, Kirsten B., Jensen, Allan, Kjaer, Susanne K., Anton-Culver, Hoda, Ziogas, Argyrios, Berchuck, Andrew, Khoja, Lilah, Wu, Anna H., Pike, Malcolm C., Pearce, Celeste Leigh and Lee, Alice W. (2022). Effects of risk factors for ovarian cancer in women with and without endometriosis. Fertility and Sterility, 118 (5), 960-969. doi: 10.1016/j.fertnstert.2022.07.019

Effects of risk factors for ovarian cancer in women with and without endometriosis

2021

Journal Article

Tobacco smoking and risk of thyroid cancer according to BRAFV600E mutational subtypes

Rahman, Sabbir T., Pandeya, Nirmala, Neale, Rachel E., McLeod, Donald S. A., Baade, Peter D., Youl, Philippa H., Allison, Roger, Leonard, Susan and Jordan, Susan J. (2021). Tobacco smoking and risk of thyroid cancer according to BRAFV600E mutational subtypes. Clinical Endocrinology, 95 (6), 891-900. doi: 10.1111/cen.14545

Tobacco smoking and risk of thyroid cancer according to BRAFV600E mutational subtypes

2021

Journal Article

Analgesic use and the risk of renal cell carcinoma – findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study

Bruinsma, F. J., Jordan, S., Bassett, J. K., Severi, G., MacInnis, R. J., Walsh, J., Aitken, T., Jenkins, M., Carroll, R., Jefford, M., Davis, I. D., Tucker, K., Dudding-Byth, T., English, D. R., Giles, G. G., Winship, I. and Milne, R. L. (2021). Analgesic use and the risk of renal cell carcinoma – findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study. Cancer Epidemiology, 75 102036, 102036. doi: 10.1016/j.canep.2021.102036

Analgesic use and the risk of renal cell carcinoma – findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study

2021

Journal Article

Hysterectomy and ovarian cancer – further research needed to inform clinical decision‐making

Wilson, Louise F. and Jordan, Susan J. (2021). Hysterectomy and ovarian cancer – further research needed to inform clinical decision‐making. BJOG: An International Journal of Obstetrics and Gynaecology, 129 (1), 119-119. doi: 10.1111/1471-0528.16952

Hysterectomy and ovarian cancer – further research needed to inform clinical decision‐making

2021

Conference Publication

Bisphosphonate use and risk of ovarian cancer, a nested case-control study using national health data

Tuesley, Karen, Webb, Penelope, Protani, Melinda, Spilsbury, Katrina, Pearson, Sallie-Anne, Coory, Michael D., Donovan, Peter, Stewart, Louise M., Pandeya, Nirmala and Jordan, Susan (2021). Bisphosphonate use and risk of ovarian cancer, a nested case-control study using national health data. IEA World Congress Of Epidemiology 2021, Online, 3-6 September 2021. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ije/dyab168.667

Bisphosphonate use and risk of ovarian cancer, a nested case-control study using national health data

2021

Journal Article

Statin use and survival among women with ovarian cancer: an Australian national data-linkage study

Feng, Jia-Li, Dixon-Suen, Suzanne C., Jordan, Susan J. and Webb, Penelope M. (2021). Statin use and survival among women with ovarian cancer: an Australian national data-linkage study. British Journal of Cancer, 125 (5), 766-771. doi: 10.1038/s41416-021-01460-4

Statin use and survival among women with ovarian cancer: an Australian national data-linkage study

2021

Journal Article

Colorectal cancer outcomes in people with severe mental illness cohort (COSMIC): a protocol for an Australian retrospective cohort using linked administrative data

Protani, Melinda M., Jordan, Susan J., Kendall, Bradley J., Siskind, Dan, Lawrence, David, Sara, Grant, Brophy, Lisa and Kisely, Steve (2021). Colorectal cancer outcomes in people with severe mental illness cohort (COSMIC): a protocol for an Australian retrospective cohort using linked administrative data. BMJ Open, 11 (6) 044737, e044737. doi: 10.1136/bmjopen-2020-044737

Colorectal cancer outcomes in people with severe mental illness cohort (COSMIC): a protocol for an Australian retrospective cohort using linked administrative data

2021

Journal Article

Risk of thyroid cancer following hysterectomy

Rahman, Sabbir T., Pandeya, Nirmala, Neale, Rachel E., McLeod, Donald S.A., Baade, Peter D., Youl, Philippa H., Allison, Roger, Leonard, Susan and Jordan, Susan J. (2021). Risk of thyroid cancer following hysterectomy. Cancer Epidemiology, 72 101931, 1-8. doi: 10.1016/j.canep.2021.101931

Risk of thyroid cancer following hysterectomy

2021

Journal Article

Is there sufficient evidence to recommend women diagnosed with endometrial cancer take a statin: Results from an Australian record-linkage study

Feng, Jia-Li, Dixon-Suen, Suzanne C., Jordan, Susan J. and Webb, Penelope M. (2021). Is there sufficient evidence to recommend women diagnosed with endometrial cancer take a statin: Results from an Australian record-linkage study. Gynecologic Oncology, 161 (3), 858-863. doi: 10.1016/j.ygyno.2021.04.001

Is there sufficient evidence to recommend women diagnosed with endometrial cancer take a statin: Results from an Australian record-linkage study

2021

Journal Article

Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins

Phung, Minh Tung, Lee, Alice W., Wu, Anna H., Berchuck, Andrew, Cho, Kathleen R., Cramer, Daniel W., Doherty, Jennifer A., Goodman, Marc T., Hanley, Gillian E., Harris, Holly R., McLean, Karen, Modugno, Francesmary, Moysich, Kirsten B., Mukherjee, Bhramar, Schildkraut, Joellen M., Terry, Kathryn L., Titus, Linda, Jordan, Susan J., Webb, Penelope M., Pike, Malcolm C. and Pearce, Celeste Leigh (2021). Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins. Cancer Epidemiology, Biomarkers and Prevention, 30 (5) cebp.EPI, 927-935. doi: 10.1158/1055-9965.EPI-20-1355

Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins

2021

Journal Article

Hysterectomy and risk of breast, colorectal, thyroid and kidney cancer - an Australian data linkage study

Wilson, Louise F., Tuesley, Karen M., Webb, Penelope M., Dixon-Suen, Suzanne C., Stewart, Louise M. and Jordan, Susan J. (2021). Hysterectomy and risk of breast, colorectal, thyroid and kidney cancer - an Australian data linkage study. Cancer Epidemiology Biomarkers and Prevention, 30 (5), 904-911. doi: 10.1158/1055-9965.epi-20-1670

Hysterectomy and risk of breast, colorectal, thyroid and kidney cancer - an Australian data linkage study

2021

Journal Article

Statin use and survival following a diagnosis of ovarian cancer: a prospective observational study

Majidi, Azam, Na, Renhua, Jordan, Susan J, De Fazio, Anna, Webb, Penelope M and OPAL Study Group (2021). Statin use and survival following a diagnosis of ovarian cancer: a prospective observational study. International Journal of Cancer, 148 (7) ijc.33333, 1608-1615. doi: 10.1002/ijc.33333

Statin use and survival following a diagnosis of ovarian cancer: a prospective observational study

2020

Journal Article

Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium

Jordan, Susan J., Na, Renhua, Weiderpass, Elisabete, Adami, Hans-Olov, Anderson, Kristin E., van den Brandt, Piet A., Brinton, Louise A., Chen, Chu, Cook, Linda S., Doherty, Jennifer A., Du, Mengmeng, Friedenreich, Christine M., Gierach, Gretchen L., Goodman, Marc T., Krogh, Vittorio, Levi, Fabio, Lu, Lingeng, Miller, Anthony B., McCann, Susan E., Moysich, Kirsten B., Negri, Eva, Olson, Sara H., Petruzella, Stacey, Palmer, Julie R., Parazzini, Fabio, Pike, Malcolm C., Prizment, Anna E., Rebbeck, Timothy R., Reynolds, Peggy ... Webb, Penelope M. (2020). Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium. International Journal of Cancer, 148 (9), 2068-2078. doi: 10.1002/ijc.33360

Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium

Funding

Current funding

  • 2025 - 2029
    Addressing Critical Knowledge Gaps to Improve Outcomes in Ovarian, Endometrial and Thyroid Cancers
    NHMRC Investigator Grants
    Open grant
  • 2023 - 2026
    Understanding the variation in the use of hysterectomy to improve outcomes for women with heavy menstrual bleeding
    HCF Research Foundation
    Open grant
  • 2022 - 2027
    Optimising Care: Phase III Trial in women with metastatic breast cancer to improve quality of life via exercise and diet (Stream 6)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2021 - 2025
    Hysterectomy, Oophorectomy and Long-term chronic Disease - the HOLD study
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2026
    Ovarian cancer: investigating Variation in care and survival, Aetiology and Risk factors to Improve outcomes in Australia via National data linkage. The OVARIAN study.
    Queensland Institute of Medical Research
    Open grant

Past funding

  • 2023 - 2024
    National Pancreatic Cancer Roadmap Early Implementation Priorities: Developing tools and guidelines for early diagnosis of pancreatic cancer
    Cancer Australia
    Open grant
  • 2020 - 2021
    Investigating the Potential to Use Chronic Disease Medicines for Cancer Chemoprevention
    Tour de Cure
    Open grant
  • 2019 - 2025
    What is the impact of the National Bowel Cancer Screening Program on colorectal cancer outcomes for people over the age of 50 with severe mental illness?
    Cancer Council Australia
    Open grant
  • 2019 - 2021
    IMPROVE - Investigating Medication re-Purposing to Reduce risk of OVarian cancer and Extend survival
    NHMRC Project Grant
    Open grant
  • 2011 - 2012
    Collaborative Australian Renal cell carcinoma Epidemiology Study (CARES) (NHMRC Project Grant administered by the Cancer Council Victoria)
    Cancer Council Victoria
    Open grant
  • 2011 - 2012
    The rise and rise of thyroid cancer: epidemic or over-diagnosis
    UQ Early Career Researcher
    Open grant
  • 2010 - 2011
    ResTeach 2010 0.1 FTE School of Population Health
    UQ ResTeach
    Open grant
  • 2008 - 2012
    NHMRC Training Fellowship (Aust. Based Public Health): Changing risk factors and cancer outcomes in a transitional Thai prospective cohort
    NHMRC Training (Postdoctoral) Fellowship
    Open grant

Supervision

Availability

Professor Susan Jordan is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Available projects

  • Hysterectomy, Oophorectomy and Long-term chronic Disease - the HOLD study

    This project will be based on a newly funded NHMRC Ideas grant that aims to investigate the long term health outcomes following hysterectomy. The study is broad so the student would select parts of the work, or methodological issues around the work, to focus on. Below is a breif description of the study background, aims and methods:

    Each year >27,000 Australian women have a hysterectomy for a benign condition, often with removal of one or both ovaries (oophorectomy). This surgery can profoundly affect women’s reproductive hormones and may influence risk of chronic conditions such as ischaemic heart disease (IHD) and cancer. Despite this, the long-term health effects of these procedures are unclear because few high quality studies have been undertaken and important potential effect modifiers such as menopausal hormone therapy (MHT) or surgery indication have been infrequently addressed. As a result, existing clinical guidelines are conflicting meaning treatment decisions are based only on short-term rather than long-term outcomes.

    AIMS: 1) To assess the association between hysterectomy with & without oophorectomy and risk of a) cancer (overall & by type); b) other chronic disease including IHD, stroke & hip fracture; & c) all cause & cause-specific mortality. 2) To determine whether associations vary by age at procedure or MHT use.

    METHODS: We will address the evidence gap by conducting a whole-of-population, cross-jurisdictional data linkage study including hospital morbidity, cancer, medicines, and death data.

    SIGNIFICANCE: Our study is timely and clinically relevant given the availability of less invasive treatments for benign gynaecological conditions and the substantial decrease in MHT use in Australia since 2002. Unique in its size, scope, data quality and approach, our study will provide new high-quality evidence to inform clinical guidelines and enable informed decisions about whether hysterectomy is the best treatment for a woman’s short and long-term health.

Supervision history

Current supervision

  • Doctor Philosophy

    Hysterectomy, oophorectomy and long-term Chronic disease

    Principal Advisor

    Other advisors: Dr Louise Wilson, Dr Karen Tuesley

  • Doctor Philosophy

    Tailored survivorship care: exploring the incidence, survival and economics of breast cancer recurrences

    Associate Advisor

  • Doctor Philosophy

    Using population data to identify treatment gaps and lifestyle interventions that may improve outcomes for people with ovarian cancer

    Associate Advisor

Completed supervision

Media

Enquiries

For media enquiries about Professor Susan Jordan's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au